The Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists will Gather for the 2023 Tandem Meetings to Improve the Lives of Patients with Blood-Related Disorders and Solid Tumors.

Virtual workshop on Nov. 17-18 bridges the gap between critical stakeholders to pinpoint today's challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.

American Society for Transplantation and Cellular Therapy (ASTCT) is pleased to announce that Owhofasa Agbedia, MD, MPH, has been selected by the American Society of Hematology (ASH), the Center of International Blood and Marrow Transplant Research (CIBMTR), and ASTCT to receive the ASH-CIBMTR-ASTCT Career Development Award.

American Society for Transplantation and Cellular Therapy (ASTCT) presented top awards to leaders in the field of transplantation and cellular therapy at the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®

Studies offer insight into who might benefit from interferon for treatment of a rare blood cancer

Friendly Community Walks to Advance Awareness & Accelerate Research for Myelodysplastic Syndromes - a Rare Blood Cancer

Walks are Elevating the Conversation Around the Unmet Needs of Those Living with MDS

Having two mutated copies of the TP53 gene - as opposed to a single mutated copy - is associated with worse outcomes in myelodysplastic syndrome and acute myeloid leukemia.

South Florida internet marketing company to support blood cancer research non-profit with dollars and manpower resources

35 year old receives stem cells from non identical donor - lives on to tell the story